In addition, patients with PAD also showed increased PRL and PRA compared to VV disease, which raised cautionary concerns about increased renin phenotypes and applications of direct vasodilators in PAD and other arterial diseases. The gene discussed is S100A6; the disease is peripheral arterial disease.